Academic literature on the topic 'Bac7'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Bac7.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Bac7"
Armas, Federica, Adriana Di Stasi, Mario Mardirossian, Antonello A. Romani, Monica Benincasa, and Marco Scocchi. "Effects of Lipidation on a Proline-Rich Antibacterial Peptide." International Journal of Molecular Sciences 22, no. 15 (July 26, 2021): 7959. http://dx.doi.org/10.3390/ijms22157959.
Full textZanetti, M., L. Litteri, R. Gennaro, H. Horstmann, and D. Romeo. "Bactenecins, defense polypeptides of bovine neutrophils, are generated from precursor molecules stored in the large granules." Journal of Cell Biology 111, no. 4 (October 1, 1990): 1363–71. http://dx.doi.org/10.1083/jcb.111.4.1363.
Full textMarlow, Victoria L., Andreas F. Haag, Hajime Kobayashi, Vivien Fletcher, Marco Scocchi, Graham C. Walker, and Gail P. Ferguson. "Essential Role for the BacA Protein in the Uptake of a Truncated Eukaryotic Peptide in Sinorhizobium meliloti." Journal of Bacteriology 191, no. 5 (December 12, 2008): 1519–27. http://dx.doi.org/10.1128/jb.01661-08.
Full textSola, Riccardo, Mario Mardirossian, Bertrand Beckert, Laura Sanghez De Luna, Dennis Prickett, Alessandro Tossi, Daniel N. Wilson, and Marco Scocchi. "Characterization of Cetacean Proline-Rich Antimicrobial Peptides Displaying Activity against ESKAPE Pathogens." International Journal of Molecular Sciences 21, no. 19 (October 6, 2020): 7367. http://dx.doi.org/10.3390/ijms21197367.
Full textTomasinsig, Linda, Marco Scocchi, Romina Mettulio, and Margherita Zanetti. "Genome-Wide Transcriptional Profiling of the Escherichia coli Response to a Proline-Rich Antimicrobial Peptide." Antimicrobial Agents and Chemotherapy 48, no. 9 (September 2004): 3260–67. http://dx.doi.org/10.1128/aac.48.9.3260-3267.2004.
Full textBenincasa, Monica, Marco Scocchi, Elena Podda, Barbara Skerlavaj, Lucilla Dolzani, and Renato Gennaro. "Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates." Peptides 25, no. 12 (December 2004): 2055–61. http://dx.doi.org/10.1016/j.peptides.2004.08.004.
Full textPodda, Elena, Monica Benincasa, Sabrina Pacor, Fulvio Micali, Maura Mattiuzzo, Renato Gennaro, and Marco Scocchi. "Dual mode of action of Bac7, a proline-rich antibacterial peptide." Biochimica et Biophysica Acta (BBA) - General Subjects 1760, no. 11 (November 2006): 1732–40. http://dx.doi.org/10.1016/j.bbagen.2006.09.006.
Full textKrizsan, Andor, Daniel Knappe, and Ralf Hoffmann. "Influence of theyjiL-mdtMGene Cluster on the Antibacterial Activity of Proline-Rich Antimicrobial Peptides Overcoming Escherichia coli Resistance Induced by the Missing SbmA Transporter System." Antimicrobial Agents and Chemotherapy 59, no. 10 (July 13, 2015): 5992–98. http://dx.doi.org/10.1128/aac.01307-15.
Full textDonati, Manuela, Antonietta Di Francesco, Maria Di Paolo, Natascia Fiani, Monica Benincasa, Renato Gennaro, Paola Nardini, Claudio Foschi, and Roberto Cevenini. "Activity of Cathelicidin Peptides against Simkania negevensis." International Journal of Peptides 2011 (April 5, 2011): 1–3. http://dx.doi.org/10.1155/2011/708710.
Full textZahn, Michael, Bjorn Kieslich, Nicole Berthold, Daniel Knappe, Ralf Hoffmann, and Norbert Strater. "Structural Identification of DnaK Binding Sites within Bovine and Sheep Bactenecin Bac7." Protein & Peptide Letters 21, no. 4 (February 2014): 407–12. http://dx.doi.org/10.2174/09298665113206660111.
Full textDissertations / Theses on the topic "Bac7"
Mardirossian, Mario. "Internal targets and killing mechanism of the cathelicidin Bac7 in Gram-negative bacteria." Doctoral thesis, Università degli studi di Trieste, 2013. http://hdl.handle.net/10077/8640.
Full textBac7(1-35) is the smallest fragment of the proline-rich cathelicidin Bac7 that shows the same antibacterial activity as the whole natural peptide of 60 residues. In this work, we remarked that the unique gene whose deletion can confer resistance to E. coli against Bac7(1-35) is sbmA, coding for an inner membrane protein involved in the penetration of this peptide into bacterial cells. Moreover, we provided evidence that SbmA is also involved in the transmembrane transport of a fragment of another proline-rich antimicrobial peptide, arasin1(1-23), isolated from the spider crab. These findings suggest a general role of this membrane protein in the uptake of proline-rich antimicrobial peptides (PR-AMPs) into Gram-negative bacteria. We then measured the intrabacterial concentration reached by Bac7(1-35) in E. coli, and observed that this increases from micromolar in the medium to millimolar within the bacterial cell, suggesting that it may bind to cytosolic structures. For this reason, we looked for possible interactions between Bac7(1-35) and macromolecules involved in viable processes of bacteria. These studies showed that Bac7(1-35) completely inhibits in vitro the transcription/translation process starting from a concentration of 50 μM. Then we demonstrated that inhibition is: i) specific for Bac7(1-35), since it is not exerted by other cathelicidin-derived AMPs not belonging to the Prorich group, and ii) not stereo-specific, since it is exerted at the same level by the all-D isomer of Bac7(1-35). We also demonstrated the ability of Bac7(1-35) to bind DNA in vitro, but we excluded that this binding may represent the primary mechanism of bactericidal action. We also showed that the peptide does not significantly affect in vitro the transcription process, deducing that the inhibition of the transcription/translation targets primarily the translation process. We verified these data in vivo on E. coli cells measuring the incorporation of radioactive precursors of bacterial macromolecules. We observed that the exposure of bacteria to Bac7(1-35) inhibited the incorporation of radioactive leucine, but not of radioactive thymidine and uridine, indicating a specific block at the protein synthesis level and not of DNA and RNA synthesis. In the near future, a clearer definition of the intrabacterial target(s) of Bac7(1-35) would hopefully lead to the experimentation of this molecule or of its derivatives as a new generation antibiotic drug.
Bac7(1-35) è il più breve frammento del peptide Bac7, una catelicidina ricca in prolina di 60 residui, dotato della stessa attività battericida del peptide intero. In questo lavoro di tesi, abbiamo rimarcato che sbmA è l’unico gene la cui delezione conferisce ad E. coli una resistenza a Bac7(1- 35). Tale gene codifica per una proteina della membrana interna coinvolta nell’ingresso del peptide nel citoplasma della cellula batterica. Inoltre, abbiamo dimostrato che SbmA è coinvolta anche nel trasporto transmembrana di un frammento di un altro peptide antimicrobico, l’arasina1(1-23). Tali risultati suggeriscono che questa proteina giochi un ruolo generale nell’internalizzazione di peptidi antimicrobici ricchi in prolina nei batteri Gram-negativi. Abbiamo quindi misurato la concentrazione intrabatterica raggiunta da Bac7(1-35) in E. coli e abbiamo osservato che questa aumenta da valori micromolari nel terreno di coltura a millimolari nel citosol batterico, suggerendo un suo legame a strutture interne della cellula. Per questo abbiamo cercato possibili interazioni tra il peptide e macromolecole coinvolte in processi vitali del batterio. Con questi studi abbiamo appurato che Bac7(1-35) in vitro inibisce completamente il processo di trascrizione/traduzione a partire da una concentrazione di 50 μM. Successivamente abbiamo dimostrato che questa inibizione è una peculiarità di Bac7(1-35), in quanto altri AMP derivati da catelicidine ma non ricchi in prolina non hanno dimostrato un’attività comparabile. Inoltre, questa inibizione non è stereo-specifica, in quanto anche l’isomero D di Bac7(1-35) blocca tale processo esattamente come il suo isomero L. Abbiamo inoltre dimostrato la capacità di Bac7(1-35) di legare in vitro il DNA, ma abbiamo escluso che tale legame rappresenti il meccanismo primario della sua attività battericida. Abbiamo anche dimostrato che il peptide non interferisce in vitro in maniera significativa con il processo di trascrizione, deducendo che l’effetto osservato sul processo di trascrizione/traduzione fosse da attribuirsi prevalentemente all’inibizione della traduzione. Abbiamo verificato tali dati in vivo su cellule di E. coli misurando l’incorporazione di precursori radioattivi delle macromolecole batteriche. Abbiamo osservato che l’esposizione di batteri a Bac7(1-35) bloccava l’incorporazione di leucina radioattiva ma non di timidina ed uridina, indicando un blocco specifico della sintesi proteica ma non di quelle di DNA e RNA. In futuro, una definizione ancora più chiara del target intrabatterico di Bac7(1-35) potrebbe portare alla sperimentazione di tale molecola o di suoi analoghi come farmaci antibiotici di nuova generazione.
XXV Ciclo
1985
Chettaf, Aïssa. "Contribution à l'étude du séchage par rayonnement infrarouge : Application au séchage en couche mince d'une enduction." Valenciennes, 1994. https://ged.uphf.fr/nuxeo/site/esupversions/9a259158-201e-4807-bac7-56fdaf6a482b.
Full textPelillo, Chiara. "Therapeutic potential of BAC7(I-35), a Proline-rich Antimicrobial Peptide: in vitro and in vivo studies and Pegylation strategy to improve its bioavailability." Doctoral thesis, Università degli studi di Trieste, 2011. http://hdl.handle.net/10077/5978.
Full textThe antimicrobial peptides (AMPs) are an important component of the innate defense against invading microorganisms, are widespread in nature and may have multiple and diversified mechanisms of bactericidal action. In addition to their direct antimicrobial activity the are also involved in other biological processes. The aim of this project was to investigate the in vivo activity of Bac7(1-35), a bovine proline-rich antimicrobial peptide, having in mind its possible use as a lead compound for the development of novel anti-infective agents. Before moving to animal models of infection, the in vitro stability of the peptide in the presence of murine and human serum or plasma as well as its biodistribution in mouse were investigated. Antibacterial activity assays against Salmonella enterica showed that the presence of murine blood components largely inhibits the antibacterial activity of the peptide. On the contrary, in human serum and plasma Bac7(1-35) maintains its efficacy. This is due to the more rapid degradation by proteases of murine blood. The in vivo biodistribution of Bac7(1-35) was investigated by using a time-domain optical imaging apparatus and a fluorescently-labeled Bac7(1-35) derivative. The compound reaches the kidney and the bladder respectively 1 and 3 hours after i.p. injection. The in vivo and ex vivo analyses performed after 24 h confirm that the compound has been totally excreted. A mouse model of S. typhimurium infection was set up and used to test the therapeutic efficacy of Bac7(1-35). Treatment of infected mice with the peptide injected i.p. immediately after a lethal, intraperithoneal bacterial challenge, increased the mean survival time and reduced significantly the number of viable bacterial cells in liver and spleen of treated mice at 3 days post-inoculum. In 1/3 of the organ homogenates, the bacterial presence was undetectable and this result matches the percentage of cured animals (35%). In an attempt to improve its pharmacokinetic profile, the peptide was conjugated with polyethylene glycol (PEG), a non-toxic, non-immunogenic and FDA-approved polymer. Different strategies of pegylation have been considered to find the best method in terms of chemical yield and of maintenance of biological activity. Pegylation via a thioether ligation resulted the best strategy to obtain a slow active peptide release in human blood components with a reduced renal clearance and an increased bioavailability of Bac7(1-35), as biodistribution analyses demonstrated. Several important pathogens, such as S. enterica, cause disease by surviving and replicating within host cells. Since many AMPs have also immunomodulatory activities, we investigated the effect of Bac7(1-35) on the interaction between macrophages and Salmonella. We carried out phagocytosis assays with macrophages and the results suggest that Bac7(1-35) plays a positive modulatory effect on this function. Phagocytosis assays were also performed to determine if Bac7(1-35) could inhibit survival and replication of intracellular Salmonella. The results show that the peptide inhibits the replication of intracellular Salmonella, suggesting that it can exert its antibacterial activity within eukaryotic cells. Further studies are required to fully understand the details of the Bac7(1-35) biological activities. The results obtained provide encouraging evidence for future investigations on Bac7(1-35) and on the pegylated form Bac7(1-35)CAM-PEG20k also in other models of infection and with different intracellular pathogens.
XXIII Ciclo
1981
Runti, Giulia. "New insights into the architecture and function of SbmA, an unusual transporter of the inner membrane of E. coli." Doctoral thesis, Università degli studi di Trieste, 2012. http://hdl.handle.net/10077/7409.
Full textSbmA/BacA è una proteina della membrana interna presente nei batteri Gram negativi e caratterizzata da omologia di sequenza con i domini transmembrana (TMDs) dei sistemi di trasporto di tipo ABC. Ceppi di E. coli con una delezione completa del gene sbmA mostrano un’aumentata resistenza al peptide antimicrobico Bac7 e ad altri peptidi ricchi in prolina a seguito di una loro ridotta internalizzazione. Gli omologhi di SbmA in altre specie sono essenziali per instaurare un’infezione cronica sia in ospiti di origine vegetale che animale. Lo scopo del presente lavoro è stato caratterizzare l’organizzazione e la funzione del sistema di trasporto rappresentato da SbmA in E. coli. Mediante saggi di cromatografia di affinità e di anisotropia a fluorescenza, è stato mostrato come SbmA sia in grado di legare Bac7 senza la necessità di una proteina di legame del substrato (SBP). Inoltre, mediante la tecnica del doppio ibrido in batterio e saggi di crosslinking in vitro, è stato mostrato come SbmA formi dimeri sia in vivo sia in vitro. Saggi di citofluorimetria in presenza di diversi inibitori metabolici indicano come la presenza di un gradiente protonico sia essenziale per garantire il trasporto del peptide attraverso la membrana batterica, trasporto che sembra essere indipendente dall’energia derivata dall’idrolisi dell’ATP. Allo scopo di identificare possibili interattori di SbmA, è stato analizzato il locus genomico di sbmA ed è stato dimostrato che il gene yaiW, localizzato a valle di sbmA, forma con quest’ultimo un’unica unità trascrizionale. Sebbene i due geni siano cotrascritti, le corrispondenti proteine non sembrano interagire né a livello citoplasmatico né di membrana interna. Tuttavia, l’interazione tra queste due proteine a livello periplasmico non può essere esclusa ed il coinvolgimento di YaiW nell’internalizzazione di Bac7 mediata da SbmA può essere ipotizzato sulla base dell’aumentata resistenza al peptide mostrata dal ceppo con una delezione completa del gene yaiW. Dal vaglio in vivo dell’intero proteoma di E. coli versus SbmA mediante il sistema BACTH non è stato identificato alcun dominio di legame dell’ATP, rafforzando quindi l’ipotesi che il sistema di trasporto rappresentato da SbmA non richieda l’idrolisi dell’ATP come fonte di energia. Questo studio ha permesso di identificare 9 possibili interattori di SbmA, tra i quali la proteina della membrana interna FieF, coinvolta nell’efflusso di ioni Zn(II) dalla cellula batterica. E’ stato mostrato come FieF sia coinvolta nell’internalizzazione di Bac7 mediata da SbmA e come l’espressione di sbmA sia modulata dagli ioni Zn(II) in maniera complessa, suggerendo un possibile ruolo per questa proteina nella risposta allo stress da parte del batterio. Questi risultati suggeriscono come SbmA sia un insolito trasportatore di peptidi derivato dalla famiglia dei trasportatori ABC, che ha successivamente perso e/o cambiato nel corso dell’evoluzione alcune caratteristiche, come ad esempio la necessità di una proteina di legame del substrato o la fonte di energia richiesta per il trasporto dei substrati. Inoltre, l’interazione osservata tra le due proteine SbmA e FieF potrebbe suggerire un possibile ruolo della prima nel processo di detossificazione dello zinco, attività che potrebbe essere modulata dal legame di un substrato di natura peptidica a SbmA. Infine, la regolazione dell’espressione di sbmA mediata dagli ioni Zn(II) potrebbe avere un ruolo fisiologico nell’ospite in quanto promuove una maggiore suscettibilità dei batteri ai peptidi antimicrobici ed è in grado di attivare effettori cellulari come i neutrofili.
SbmA/BacA is a protein of the inner membrane of many Gram negative bacteria, predicted to be the transmembrane domain of an ABC transport system. sbmA-deleted E. coli strain shows an increased resistance to the antimicrobial peptide Bac7 and other proline-rich peptides due to their reduced uptake. In addition, BacA of some Gram negative species is essential to establish chronic infection in animal and plant hosts. The aim of this study was to characterize the architecture and function of the SbmA transport system in E. coli. By affinity chromatography and fluorescence anisotropy assays we showed that SbmA is able to bind Bac7 also without the requirement of a substrate-binding protein. By using a bacterial two-hybrid BACTH system and in vitro crosslinking assay we showed that SbmA forms dimers both in vivo and in vitro. Flow cytometry analysis using different metabolic inhibitors indicate that the proton motive force rather than ATP hydrolysis may represent the driving force for the translocation of peptide substrates. Searching for possible interactors of SbmA, we showed that the yaiW gene, located downstream of sbmA, is part of the same operon. Even if the two genes are cotranscribed, the corresponding proteins do not seem to interact neither at the cytoplasmic nor at the inner membrane level. However, ΔyaiW strain showed an increased resistance to Bac7 suggesting the involvement of this protein in the SbmA-mediated uptake of the peptide. An in vivo screening of the whole proteome of E. coli against SbmA by the BACTH system did not identify any nucleotide-binding domain of the transporter, strengthening the hypothesis that the transport system is energized by a mechanism different from ATP hydrolysis. Two-hybrid analysis allowed us to fish out 9 potential interactors and among those our attention was focused on FieF, an inner membrane protein involved in zinc efflux from the bacterial cell. We demonstrated that FieF is involved in the SbmA-mediated uptake of Bac7 and that the expression of sbmA is modulated by zinc ions in a complex manner, suggesting a stress role for this protein in bacteria. Overall, these findings suggest that SbmA is an unusual peptide transporter likely derived from the widespread ABC transporters, which has evolutionary lost/changed some typical features of this transport systems, such as the request of a substrate-binding protein and the ATP binding domain. The interaction between SbmA and FieF points to a possible involvement of the former in zinc detoxification, a function which may be modulated by the binding of an unidentified peptide substrate. The regulation of the expression of SbmA by zinc ions might have a physiological relevance in the host because it makes the target bacteria more susceptible to the AMPs and activates cellular effectors such as the neutrophils.
XXIV Ciclo
1984
Mawson, Mark. "Interactive fluid-structure interaction with many-core accelerators." Thesis, University of Manchester, 2014. https://www.research.manchester.ac.uk/portal/en/theses/interactive-fluidstructure-interaction-with-manycore-accelerators(a4fc2068-bac7-4511-960d-41d2560a0ea1).html.
Full textSaunders, Catherine. "Asymptotic methods applied to problems of steady-streaming flows and acoustic radiation forces." Thesis, University of Manchester, 2014. https://www.research.manchester.ac.uk/portal/en/theses/asymptotic-methods-applied-to-problems-of-steadystreaming-flows-and-acoustic-radiation-forces(7c4856bd-5d9d-44b5-bac7-d2aed745f258).html.
Full textGray, Imara. "Self-esteem and self-concept in individuals with 'poor me' and 'bad me' persecutory beliefs." Thesis, Bangor University, 2009. https://research.bangor.ac.uk/portal/en/theses/selfesteem-and-selfconcept-in-individuals-with-poor-me-and-bad-me-persecutory-beliefs(60be59cb-0d54-4275-bac7-823bea6cf811).html.
Full textLindberg, Erik, and Lukas Magnusson. "WEC Back-to-back Topology." Thesis, Uppsala universitet, Institutionen för teknikvetenskaper, 2018. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-351912.
Full textJohnson, Lisa Marie. "Back to back they faced each other." Thesis, University of Iowa, 2011. https://ir.uiowa.edu/etd/993.
Full textFluhrer, Regina. "Zwei neuartige Aspartylproteasen BACE-1 und BACE-2." Diss., lmu, 2003. http://nbn-resolving.de/urn:nbn:de:bvb:19-14423.
Full textBooks on the topic "Bac7"
1906-, Back Custer, and Back/Bach Genealogy Society, eds. A Back family history: The story of a major branch of the Bach/Back family. [United States]: Back/Bach Genealogy Society, 1994.
Find full textMoses, Itamar. Back back back. New York: Samuel French, 2009.
Find full textBrebrayer, David. Evidence based management of low back pain. Sudbury,ON: NEORCC, 2004.
Find full textCommission royale sur le transport des voyageurs au Canada. Étude de l'industrie des traversiers au Canada. Ottawa, Ont: Division de la recherche, Commission royale sur le transport des voyageurs au Canada, 1991.
Find full textKatrin, Kintzel, and Schrastetter Lydia, eds. Strong and healthy back: Stay flexible - live without pain. New York: Barnes & Noble, 2006.
Find full textApplied anatomy of the back. Berlin: Springer-Verlag, 1985.
Find full textBack strengthening for health & fitness. New York: Sterling Innovation, 2008.
Find full textKennedy, Robert. Herculean back! New York: Sterling Pub. Co., 1988.
Find full textIrv, Rubenstein, ed. Exercise ideas for core strengthening. Tacoma, Wash: Visual Health Information, 2005.
Find full textInnere Harmonie durch Bach-Blüten: Natürlich und wirksam ; bei seelischer Belastung, bei Krankheiten, in Notfällen. 2nd ed. München: Gräfe und Unzer, 1995.
Find full textBook chapters on the topic "Bac7"
Fretheim, B. Solveig. "Back to Bach." In Narratives and Reflections in Music Education, 237–54. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-28707-8_18.
Full text"8 Literatur." In Familie - nein danke?!, 225–35. Göttingen: Vandenhoeck & Ruprecht GmbH & Co. KG, 2012. http://dx.doi.org/10.13109/9783666401824.back.
Full text"Quellen." In Meine andere Welt, 153–56. Göttingen: Vandenhoeck & Ruprecht GmbH & Co. KG, 2012. http://dx.doi.org/10.13109/9783666401886.back.
Full text"Namen-und Sachregister, Stellenregister." In Ausonius an Paulinus von Nola, 357–76. Göttingen: Vandenhoeck & Ruprecht GmbH & Co. KG, 2012. http://dx.doi.org/10.13109/9783647252971.back.
Full textOmar, Haim. "Anzeigen." In Autorität durch Beziehung, 263–64. Vandenhoeck & Ruprecht, 2016. http://dx.doi.org/10.13109/9783666490774.back.
Full text"Back Pain." In Quick Reference Guide to Pediatric Care, 100–105. 2nd ed. American Academy of Pediatrics, 2017. http://dx.doi.org/10.1542/9781610021128-back.
Full text"Index." In Biodiesel Science and Technology, 822–40. Elsevier, 2010. http://dx.doi.org/10.1533/back-matter.
Full text"Back Pain." In Quick Reference Guide to Pediatric Care, 114–18. American Academy of Pediatrics, 2005. http://dx.doi.org/10.1542/9781581106220-part01-back.
Full text"Index." In Functional Assessment of Wetlands, 661–72. Elsevier, 2009. http://dx.doi.org/10.1533/9781845695163.back-matter.
Full text"Index." In Improving the Sensory and Nutritional Quality of Fresh Meat, 647–64. Elsevier, 2009. http://dx.doi.org/10.1533/9781845695439.back-matter.
Full textConference papers on the topic "Bac7"
Hertanto, Anthony, Honggang Liu, Davit Yeghikyan, B. Gangadhar Rayaprol, Nazir P. Kherani, and Stefan Zukotynski. "Back Amorphous-Crystalline Silicon Heterojunction (bach) photovoltaic device." In 2009 34th IEEE Photovoltaic Specialists Conference (PVSC). IEEE, 2009. http://dx.doi.org/10.1109/pvsc.2009.5411466.
Full textPfenniger, Daniel. "Fractal geometry of interstellar gas and dark matter in HI disks." In Back to the Galaxy. AIP, 1992. http://dx.doi.org/10.1063/1.43943.
Full textWilson, Thomas L. "The cosmological constant and dark matter in the Galaxy." In Back to the Galaxy. AIP, 1992. http://dx.doi.org/10.1063/1.43944.
Full textde Geus, Eugène J. "Formation of massive stars at the edge of our Galaxy." In Back to the Galaxy. AIP, 1992. http://dx.doi.org/10.1063/1.43974.
Full textDettmar, Ralf-Jürgen. "The ionization of diffuse ionized gas in galaxies: A comparison with the Reynolds-layer in the Milky Way." In Back to the Galaxy. AIP, 1992. http://dx.doi.org/10.1063/1.43989.
Full textPetuchowski, S. J., and C. L. Bennett. "Probes of the warm ionized medium in the disk of the Galaxy." In Back to the Galaxy. AIP, 1992. http://dx.doi.org/10.1063/1.43990.
Full textWeinberg, Martin D. "Distribution of stars in the disk." In Back to the Galaxy. AIP, 1992. http://dx.doi.org/10.1063/1.44000.
Full textWyse, Rosemary, and Gerard Gilmore. "The dynamical evolution of the Galaxy." In Back to the Galaxy. AIP, 1992. http://dx.doi.org/10.1063/1.44001.
Full textBinney, James, and Ortwin Gerhard. "Dynamics of the galactic bulge-bar." In Back to the Galaxy. AIP, 1992. http://dx.doi.org/10.1063/1.43925.
Full textBlitz, Leo. "Photometric evidence for the bar." In Back to the Galaxy. AIP, 1992. http://dx.doi.org/10.1063/1.43926.
Full textReports on the topic "Bac7"
Chase, Benjamin, Troy Unruh, and Joy Rempe. Initial Back-to-Back Fission Chamber Testing in ATRC. Office of Scientific and Technical Information (OSTI), June 2014. http://dx.doi.org/10.2172/1164850.
Full textKim, U. J., Hiroaki Shizuya, and M. I. Simon. Development of BAC libraries and integrated physical mapping of human chromosome 22 using BACs. Annual report, July 1994--June 1995. Office of Scientific and Technical Information (OSTI), December 1995. http://dx.doi.org/10.2172/639707.
Full textRiewe, Krissi. Pieced Back Together. Ames (Iowa): Iowa State University. Library, January 2019. http://dx.doi.org/10.31274/itaa.8754.
Full textMarshak, Ronni. Winning Back Customers. Boston, MA: Patricia Seybold Group, September 2002. http://dx.doi.org/10.1571/ce9-12-02cc.
Full textBinnendijk, Hans, and Alan Henrikson. Back to Bipolarity? Fort Belvoir, VA: Defense Technical Information Center, May 1999. http://dx.doi.org/10.21236/ada385982.
Full textRavindranath, R., T. Reddy, G. Salgueiro, V. Pascual, and P. Ravindran. DTLS-SRTP Handling in SIP Back-to-Back User Agents. RFC Editor, May 2016. http://dx.doi.org/10.17487/rfc7879.
Full textMorton, A. Updates for the Back-to-Back Frame Benchmark in RFC 2544. RFC Editor, May 2021. http://dx.doi.org/10.17487/rfc9004.
Full textDeSantis, G. N. Strong-back safety latch. Office of Scientific and Technical Information (OSTI), March 1995. http://dx.doi.org/10.2172/32765.
Full textStrandwitz, Nicholas, and Ben Davis. Tunneling Back-Contacted Photovoltaics. Office of Scientific and Technical Information (OSTI), July 2019. http://dx.doi.org/10.2172/1542790.
Full textKaplan, H., and V. Pascual. A Taxonomy of Session Initiation Protocol (SIP) Back-to-Back User Agents. RFC Editor, December 2013. http://dx.doi.org/10.17487/rfc7092.
Full text